Aelis Farma Future Growth
Future criteria checks 2/6
Aelis Farma's revenue and earnings are forecast to decline at 30.7% and 43.4% per annum respectively. EPS is expected to decline by 1.7% per annum. Return on equity is forecast to be -21.9% in 3 years.
Key information
-43.4%
Earnings growth rate
-1.7%
EPS growth rate
Biotechs earnings growth | 27.9% |
Revenue growth rate | -30.7% |
Future return on equity | -21.9% |
Analyst coverage | Low |
Last updated | 17 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 5 | -13 | -15 | -14 | 3 |
12/31/2025 | 12 | -5 | -12 | -6 | 3 |
12/31/2024 | 54 | 33 | 5 | 21 | 3 |
12/31/2023 | 12 | -5 | -13 | -13 | N/A |
9/30/2023 | 11 | -5 | -13 | -13 | N/A |
6/30/2023 | 10 | -6 | -13 | -13 | N/A |
3/31/2023 | 9 | -10 | -13 | -13 | N/A |
12/31/2022 | 8 | -14 | -13 | -13 | N/A |
9/30/2022 | 8 | -14 | -14 | -13 | N/A |
6/30/2022 | 7 | -14 | -14 | -14 | N/A |
3/31/2022 | 9 | -6 | 2 | 3 | N/A |
12/31/2021 | 11 | 1 | 19 | 19 | N/A |
9/30/2021 | 10 | 2 | 21 | 21 | N/A |
6/30/2021 | 9 | 3 | 24 | 24 | N/A |
3/31/2021 | 5 | 1 | 11 | 11 | N/A |
12/31/2020 | 1 | -2 | -3 | -2 | N/A |
12/31/2019 | 0 | -3 | N/A | N/A | N/A |
12/31/2018 | 0 | -3 | N/A | N/A | N/A |
12/31/2017 | 0 | -1 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AELIS's earnings are forecast to decline over the next 3 years (-43.4% per year).
Earnings vs Market: AELIS is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: AELIS is expected to become profitable in the next 3 years.
Revenue vs Market: AELIS's revenue is expected to decline over the next 3 years (-30.7% per year).
High Growth Revenue: AELIS's revenue is forecast to decline over the next 3 years (-30.7% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AELIS is forecast to be unprofitable in 3 years.